Novonix (NVNXF) Total Debt (2020 - 2025)

Novonix has reported Total Debt for 6 years, with the latest figure at $93.8 million in Q4 2025.

• For the quarter ending Q4 2025, Total Debt rose 43.17% year-over-year to $93.8 million; the trailing twelve-month figure through Dec 2025 stood at $93.8 million (up 43.17% YoY), and the FY2023 full-year result was $35.5 million, up 1.3% from the prior year.
• Total Debt for Q4 2025 stood at $93.8 million, up from $91.2 million in the prior quarter.
• The five-year high for Total Debt was $93.8 million in Q4 2025, with the low at $4.8 million in Q2 2021.
• Historically, Total Debt has averaged $49.3 million across 5 years, with a median of $37.0 million in 2022.
• Annual changes were most pronounced in 2022 — Total Debt soared 696.36% — and 2024, when it sank 51.01%.
• Novonix's Total Debt stood at $35.2 million in 2021, then dropped by 0.27% to $35.1 million in 2022, then grew by 1.3% to $35.5 million in 2023, then surged by 84.48% to $65.6 million in 2024, then surged by 43.17% to $93.8 million in 2025.
• The last three Total Debt figures came in at $93.8 million (Q4 2025), $91.2 million (Q2 2025), and $65.6 million (Q4 2024), per Business Quant data.